Literature DB >> 8239158

Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis.

M Linden1, J B Rasmussen, E Piitulainen, A Tunek, M Larson, H Tegner, P Venge, L A Laitinen, R Brattsand.   

Abstract

To assess the manifestation and location of airway inflammation in smokers with chronic bronchitis (CB) or chronic obstructive pulmonary disease (COPD), we lavaged the airways of 12 smokers with CB and 11 smokers with COPD and coexisting CB (OCB). For comparison, the airways of 5 asymptomatic smokers (AS) and 10 healthy nonsmokers (HNS) were lavaged. In all cases, the first lavage aliquot, labeled "bronchial lavage" (BL), was processed separately from the four subsequent aliquots, which were combined and labeled "bronchoalveolar lavage" (BAL). The composition of BL and BAL fluids indicate an ongoing inflammatory process in the airways of all three groups of smokers. CB patients with obstruction had significantly lower concentrations of inflammatory cells in the BL and BAL fluids compared with subjects with nonobstructed CB. Furthermore, airway obstruction, indicated by a reduced FEV1, was significantly correlated with the concentrations of glutathione (p < 0.001), myeloperoxidase (MPO; p < 0.01), and eosinophil cationic protein (ECP; p < 0.01) in BAL fluids. Taken together, these findings suggest that the manifestations of inflammation present in the airways of smokers with CB are different in those who have developed obstruction compared with those who have not.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239158     DOI: 10.1164/ajrccm/148.5.1226

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  35 in total

1.  Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.

Authors:  K Amin; A Ekberg-Jansson; C-G Löfdahl; P Venge
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

2.  Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease.

Authors:  I Rahman; W MacNee
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

3.  Efficacy of two breath condensers.

Authors:  A Davidsson; B Schmekel
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

4.  Pulmonary inflammation and crystalline silica in respirable coal mine dust: dose-response.

Authors:  E D Kuempel; M D Attfield; V Vallyathan; N L Lapp; J M Hale; R J Smith; V Castranova
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

Review 5.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

6.  Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils.

Authors:  D Stănescu; A Sanna; C Veriter; S Kostianev; P G Calcagni; L M Fabbri; P Maestrelli
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

7.  Oxidative stress and airway inflammation in severe exacerbations of COPD.

Authors:  E M Drost; K M Skwarski; J Sauleda; N Soler; J Roca; A Agusti; W MacNee
Journal:  Thorax       Date:  2005-04       Impact factor: 9.139

8.  Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles.

Authors:  Ning Zhang; Kevin P Francis; Arun Prakash; Daniel Ansaldi
Journal:  Nat Med       Date:  2013-03-03       Impact factor: 53.440

9.  Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD.

Authors:  Yudong Wen; David W Reid; Dongcheng Zhang; Chris Ward; Richard Wood-Baker; E Haydn Walters
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-10-05

Review 10.  Antioxidant therapies in COPD.

Authors:  Irfan Rahman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.